Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)

por Qian, Xiao-Long, Zhang, Jun, Li, Pei-Ze, Lang, Rong-Gang, Li, Wei-Dong, Sun, Hui, Liu, Fang-Fang, Guo, Xiao-Jing, Gu, Feng, Fu, Li
Publicado 2017

Accessory Breast Cancer Occurring Concurrently with Bilateral Primary Invasive Breast Carcinomas: A Report of Two Cases and Literature Review

por Hao, Jin-yan, Yang, Cui-cui, Liu, Fang-fang, Yang, Yi-ling, Li, Shuai, Li, Wei-dong, Li, Ya-qing, Lang, Rong-gang, Fan, Yu, Paulos, Estifanos, Zhang, Xin-min, Fu, Li
Publicado 2012